Quarter Period Statement Of Income

ONO PHARMACEUTICAL CO., LTD. - Filing #7242262

Concept 2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
Quarter period statement of income
Statement of income
Net sales
451,756,000,000 JPY
498,777,000,000 JPY
Cost of sales
120,075,000,000 JPY
109,585,000,000 JPY
Gross profit (loss)
331,681,000,000 JPY
389,192,000,000 JPY
Selling, general and administrative expenses
216,972,000,000 JPY
201,276,000,000 JPY
Selling, general and administrative expenses
Salaries
14,900,000,000 JPY
12,538,000,000 JPY
Depreciation
1,129,000,000 JPY
966,000,000 JPY
Operating profit (loss)
114,709,000,000 JPY
187,916,000,000 JPY
Non-operating income
Interest income
1,630,000,000 JPY
1,101,000,000 JPY
Dividend income
2,410,000,000 JPY
2,445,000,000 JPY
Non-operating income
4,858,000,000 JPY
5,279,000,000 JPY
Non-operating expenses
Interest expenses
1,204,000,000 JPY
30,000,000 JPY
Non-operating expenses
7,304,000,000 JPY
5,159,000,000 JPY
Ordinary profit (loss)
112,263,000,000 JPY
188,036,000,000 JPY
Extraordinary income
Extraordinary income
16,310,000,000 JPY
12,403,000,000 JPY
Extraordinary losses
Extraordinary losses
1,100,000,000 JPY
2,400,000,000 JPY
Profit (loss) before income taxes
127,473,000,000 JPY
198,039,000,000 JPY
Income taxes - current
23,641,000,000 JPY
41,265,000,000 JPY
Income taxes - deferred
1,416,000,000 JPY
3,865,000,000 JPY
Income taxes
25,057,000,000 JPY
45,130,000,000 JPY
Profit (loss)
102,415,000,000 JPY
102,415,000,000 JPY
102,415,000,000 JPY
102,415,000,000 JPY
152,909,000,000 JPY
152,909,000,000 JPY
152,909,000,000 JPY
152,909,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.